Killing of Human Lung Cancer Cells Using a New [¹¹¹In]Bleomycin Complex [¹¹¹In]BLMC

References

• Crooke S T. Bleomycin, a brief review. Bleomycin—Current Status and New Developments, S K Carter, S T Crooke, H Umezawa. Academic Press Inc., New York 1978; 1–8
   Google Scholar
• Twentyman P R, Kallman R F, Brown J M. The effect of time between x-irradiation and chemotherapy on the growth of three solid mouse tumors vs. bleomycin. Int J Radial Oncol Biol Rhys 1979; 5: 1499–1501
   PubMed Web of Science ®Google Scholar
• Wu D-Z, Zhang Y-Q, Keng P, et al. The interaction between bleomyicn and radiation on cell survival and DNA damage in mammalian cell cultures. Int J Radial Oncol Biol Phys 1985; 11: 2125–2131
   Web of Science ®Google Scholar
• Kono A, Matsushima Y, Kojima M, et al. Cobalt chelate of bleomycin. I. Physicochemical properties and distribution in tumor bearing mice. Chem Pharmacol Bull 1977; 25: 1725–1731
   PubMed Web of Science ®Google Scholar
• Nouel J P. Radioactive metal-bleomycin complex for the diagnosis of cancer. Gann Monogr Cancer Res 1976; 19: 301–316
   Google Scholar
• Thakur M L, Merrick M V, Gunasekera S W. Some pharmacological aspects of a new radiopharmaceutical, In-bleomycin. Radiopharmaceuticals Labelled Compounds, Vol. 2. Vienna. Proceedings Series IAEA. 1973, 183–193
   Google Scholar
• Robbing P J, Silberstein E B, Fortman D L. The preparation and distribution of 111In-bleomycin in mice as compared to 111InC13 for tumor scanning (abstr). J Nucl Med 1973; 14: 637
   Web of Science ®Google Scholar
• Hou D-Y, Hoch H, Johnston G S, et al. Stability of 111In-bleomycin in vivo — Properties compared with 57Co-Bleomycin. Eur J Nucl Med 1983; 8: 535–540
   PubMedGoogle Scholar
• Hou D-Y, Hoch H, Johnston G S, et al. Distribution and stability of [111In] bleomycin and its fractions in tumor-bearing mice. Int J Nucl Med Biol 1984; 11: 129–139
   PubMedGoogle Scholar
• Hou D-Y, Hoch H, Johnston G S, et al. Use of 111In-bleomycin for combining radiotherapy and chemotherapy on glioma-bearing mice. J Surg Oncol 1985; 29: 71–77
   PubMed Web of Science ®Google Scholar
• Hou D-Y, Hoch H, Johnston G S, et al. A new 111In-bleomycin complex for tumor imaging: Preparation, stability and distribution in glioma-bearing mice. J Surg Oncol 1984; 25: 168–175
   PubMed Web of Science ®Google Scholar
• Hou D-Y, Hoch H, Johnston G S, et al. A new tumor imaging agent—111In-bleomycin complex. Comparison with 67Ga-citrate and 57Co-bleomycin in tumor bearing animals. J Surg Oncol 1984; 27: 189–195
   PubMed Web of Science ®Google Scholar
• Hou D-Y, Hoch H, Johnston G S, et al. A new In-bleomycin complex for combined radiotherapy and chemotherapy. J Surg Oncol 1985; 29: 91–98
   PubMed Web of Science ®Google Scholar
• Morstyn G, Idhe D C, Lichter A S, et al. Small cell lung cancer 1973–1983: early progress and recent obstacles. Int J Rad Oncol Biol Phys 1984; 10: 515–539
   PubMed Web of Science ®Google Scholar
• Carney D N, Gazdar A F, Bepler G, et al. Establishment and identification of small lung cancer cell lines having classic and variant features. Cancer Res 1985; 45: 2913–2923
   PubMed Web of Science ®Google Scholar
• Selby P, Buick R N, Tannock I. A critical appraisal of the “human tumor stem-cell assay”. N Engl J Med 1983; 308: 129–134
   PubMed Web of Science ®Google Scholar
• Kanazawa F, Hoshi A, Shimizu E, et al. Clonogenic cell assay for carcinoma of the lung. Gann 1984; 75: 81–88
   PubMedGoogle Scholar
• Leibovitz A, Liu R, Hayes C, et al. A hypo-osmotic medium to disaggregate tumor cell clumps into viable and clonogenic assay. Int J Cell Cloning 1983; 1: 478–485
   PubMedGoogle Scholar
• Hamburger A W, Salmon S E, Kim M B, et al. Direct cloning of human ovarian carcinoma cells in agar. Cancer Res 1978; 38: 3438–3444
   PubMed Web of Science ®Google Scholar
• Hou D-Y, Ordonez J V, Cross R J, et al. Killing lung cancer cells at cell-cycle phase by a new Indium111 bleomycin complex, 111In-BLMC. J Surg Oncol 1980; 40: 73–78
   Google Scholar
• Kassis A I, Sastry K SR, Adelstein S J. Kinetics of uptake, retention, and radiotoxicity of 125IUdR in mammalian cells: implications of localized energy deposition by Auger processes. Radial Res 1987; 109: 78–89
   PubMed Web of Science ®Google Scholar
• Kassis A I, Adelstein S J, Haydock C, et al. Lethality of Auger electrons from the decay of Bromine-77 in the DNA of mammalian cells. Radial Res 1982; 90: 362–373
   PubMed Web of Science ®Google Scholar
• Bloomer W D, McLaughlin W H, Adelstein S J, et al. Therapeutic applications of Auger and alpha emitting radionuclides. Strahlentherapie 1984; 160: 755–757
   PubMedGoogle Scholar
• Chabner B A. Bleomycin. Pharmacologic Principles of Cancer Treatment, B A Chabner. W.B. Saunders Co., New York 1982; 377–386
   Google Scholar
• Povirk L F, Hogan M, Dattagupta N. Binding of bleomycin to DNA: intercalation of the bithiazole rings. Biochemistry 1979; 18: 93–101
   Google Scholar
• Oppenheimer N J, Rodriquez L O, Hecht S M. Structural studies of “active complex” of bleomycin: Assignment of ligands to the ferrous ion in a ferrous-bleomycin-carbon, monoxide complex. Proc Natl Acad Sci (USA) 1979; 76: 5616–5620
   PubMed Web of Science ®Google Scholar
• Kasai H, Naganawa H, Takita T, et al. Chemistry of bleomycin XXII Interaction of bleomycin with nucleic acid, preferential binding of guanine base and electrostatic effect of the terminal amine. J Antibiotic 1978; 31: 1316–1320
   PubMed Web of Science ®Google Scholar
• Mirabelli C K, Ting A, Huang C-H, et al. Bleomycin and talisomycin sequence-specific strand scission of DNA: A mechanism of double-strand cleavage. Cancer Res 1982; 42: 2779–2785
   PubMed Web of Science ®Google Scholar
• Fujimoto J. Radio autographic studies on the intracellular distribution of bleomycin-14C in mouse tumor cells. Cancer Res 1974; 34: 2969–2974
   PubMed Web of Science ®Google Scholar